X

We aim to transform protein production to allow universal access to biologics.

AREAS OF FOCUS

Animal Health

20 years’ experience in the development and production of animal vaccines.
200 molecules successfully produced in collaboration with public and private partners, including multiple international pharmaceutical companies.
First dossier for a veterinary vaccine produced using CrisBio® under review by EMA.

Learn more

Human Health

Building on experience in animal health, Algenex is expanding the production of proteins into human health to fully exploit the potential of its technology platforms

Learn more

LATEST NEWS

News

27/11
Technology CrisBio Science

Chrysalises as natural production units for recombinant subu...

Learn more

News

24/09
Company CrisBio Technology

Algenex inaugura su nueva planta de fabricación de vacunas e...

Inauguración de la nueva planta de Algenex en Tres Cantos (Madrid)
Learn more

News

13/09
CrisBio Company

Algenex raises €7.4 million in financing round

Algenex R&D Laboratory at Tres Cantos (Madrid)
Learn more